Regeneron Pharmaceuticals, Inc. ( REGN) Bank of America Global Healthcare Conference 2026 May 12, 2026 1:00 PM EDT ...

Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); ...

Enrollment completed six months ahead of guidance in both barzolvolimab Phase 3 chronic spontaneous urticaria studies (EMBARQ-CSU 1 and 2); Topline data expected in Q4 26; BLA submission planned for ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...

Consistently following prescribed treatments is essential for controlling chronic diseases and avoiding complications. Many patients face challenges such as side effects, regimen complexity, or ...

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2026. “Galderma’s strong first quarter results reflect our ...

Scientists say their work on fires and climate change could be lost as the agency moves its headquarters to Utah from Washington and shuts 57 research stations. By Eric Niiler Reporting from ...

Itch relief - defined as a score of ≥4 on the Peak Pruritus Numerical Rating Scale (PP-NRS) - was observed as early as Week 1, with 72% of children aged 2 to 6 and 59% of children aged 7 to 11 ...

Everyone knows the old adage about dogs being man's best friend, but you may not know that dogs might also be one of man's best hopes to treat age-related illnesses. That's because our canines develop ...

Prurigo nodularis is a chronic, debilitating, and distinct neuroimmune skin disease characterized by the presence of intense itch and thick skin nodules covering large body areas. 10-12 It is ...